Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapy

INTRODUCTION: The clinical assessment of the myocardial damage caused by anthracyclin (ANT)-therapy is difficult. Therefore a study was performed to evaluate non-invasive markers of anthracyclin-induced cardiac effects, with emphasis on course-to-course variation. METHODS: Eligible for study partici...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Broeyer, F. J. F., Osanto, S., Ritsema van Eck, H. J., van Steijn, A. Q. M. J., Ballieux, B. E. P. B., Schoemaker, R. C., Cohen, A. F., Burggraaf, J.
Format: Artigo
Idioma:Inglês
Publicat: Springer-Verlag 2008
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2515587/
https://ncbi.nlm.nih.gov/pubmed/18343950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-008-0372-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars